Baby nutrition company ByHeart raises $70M
NYC-based infant & baby nutrition company ByHeart announced it has raised $70 million in Series A funding led by Polaris Partners, D1 Capital Partners, and OCV Partners, in advance of its first infant formula product launch in 2021. Additional investors in the round include Red Sea Ventures, Sean Parker, and existing investors including Bellco Capital and affiliates of Two River.
“We founded ByHeart to unlock real choice for parents in a moment that can be overwhelming: formula and baby food products are not optional for most parents – they are crucial – which is why they must be accessible, uncompromised, holistic sources of nutrition. We want parents to feel engaged with what their baby eats and empowered as they create a foundation of health for their babies’ lives to follow.” – Ron Belldegrun, CEO of ByHeart .
With ownership of manufacturing and research & development facilities, ByHeart seeks to maximize both quality and safety for its consumers and is in a unique position to circumvent significant channel markups and invest those savings into what truly matters: hand-picked ingredients, small-batch blending, evolved nutrition science, rigorous quality controls, and ultimately an elevated consumer experience. This experience will position community and education as paramount to transforming the baby nutrition category.
After three years of building and developing its products, team and facilities, as well as a network of nutrition, regulatory and parenting experts, the company is conducting a multi-site, infant-growth monitoring clinical study in accordance with the U.S. Food and Drug Administration’s rigorous requirements, to support ByHeart’s first product launch in 2021. The Series A investment evidences investors’ confidence in the company’s considered approach.